Computer-Assisted Self-Administration of Ethanol
NCT00713492 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 229
Last updated 2026-05-22
Summary
This study will test the reliability of a procedure for self-administering ethanol (alcohol) intravenously (through a vein), using a computer-assisted method. People ordinarily self-administer alcohol through drinking alcoholic beverages, but blood alcohol levels resulting from drinking vary greatly among individuals. For research on alcohol dependence and treatment, a tool for achieving precise blood levels is needed. In addition to testing this method of alcohol administration, the study will examine self-administration behavior and resulting breath alcohol concentration, the effects of alcohol on the participants, and differences between men and women in alcohol self-administration.
Healthy normal volunteers between 21 and 45 years of age may be eligible for this study. Participants are assigned to one of two study groups. Group 1 undergoes three 7-hour study sessions and group 2 participates in two sessions, each of which includes the following procedures:
* Breathalyzer and urine tests for alcohol and illicit drug use.
* Urine pregnancy test for women.
* Light lunch.
* Questionnaire about health and recent drinking.
Alcohol infusion: Subjects are seated in a comfortable chair and instructed on how to use a computer to give themselves a short infusion of alcohol through a catheter (plastic tube) that has been inserted into a vein in their the arm. Sensors are placed on their chest to monitor heart beat and their neck to record skin blood flow. At the start of the session, subjects complete questionnaires about any drug effects and urges to drink they may be feeling. They are trained on how to use the computer to administer alcohol and are then allowed to self-administer alcohol through the catheter any time they like, as long as their peak breath alcohol level does not exceed 0.1 g% (a level that would result from ingestion of 4 to 6 drinks in most people). If that point is reached, the computer automatically inactivates self-administration until the level is lowered again. Breathalyzer readings are taken every 15 to 30 minutes. Subjects may read, watch television or videos or listen to music during the sessions.
Recovery: At the end of the 2.5 hours of self-administration, the catheter is removed and subjects can eat, read, watch television and relax in the clinic until their breath alcohol level falls below 0.02 g%, usually after 2.5 to 3 hours, when they can go home by taxi or with a pre-arranged designated driver.
...
Conditions
- Alcoholic Intoxication
Interventions
- DRUG
-
Alcohol
human laboratory alcohol consumption.
Sponsors & Collaborators
-
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
lead NIH
Principal Investigators
-
Vijay A Ramchandani, Ph.D. · National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-10-29
- Primary Completion
- 2023-12-11
- Completion
- 2023-12-11
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Interactive Effects of IV Ethanol and IV Nicotine
NCT01814410 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Trials of Ventilation Assisted Substance Elimination Via the Lung - Ethanol (VASEL - Ethanol)
NCT04229732 ·Status: UNKNOWN ·Phase: NA
-
Neural Mechanisms Underlying Alcohol Induced Disinhibition
NCT01097213 ·Status: COMPLETED
-
Using Transcutaneous Auricular Vagus Nerve Stimulation to Treat Acute Alcohol Withdrawal
NCT04159909 ·Status: WITHDRAWN ·Phase: NA
-
Oxytocin Treatment of Alcohol Dependence
NCT02251912 ·Status: COMPLETED ·Phase: PHASE2
-
Oxytocin Treatment of Alcohol Withdrawal
NCT01212185 ·Status: COMPLETED ·Phase: PHASE1
-
Non-invasive Vagal Nerve Stimulation in Alcohol Use Disorder
NCT05226130 ·Status: COMPLETED ·Phase: PHASE1
-
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
NCT02885311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Remote Treatment of Alcohol Withdrawal
NCT04858490 ·Status: COMPLETED ·Phase: NA
-
Ketamine for the Treatment for Alcohol Use Disorder in the ED
NCT05661669 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels
NCT05487404 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Impact of Vaping Ethanol in the Evaluation of Impairment
NCT03826303 ·Status: COMPLETED ·Phase: NA
-
Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans
NCT01590277 ·Status: COMPLETED ·Phase: PHASE1
-
Naltrexone Treatment for Alcoholic Women
NCT00000448 ·Status: COMPLETED ·Phase: PHASE4
-
Medication Development in Alcoholism: Acamprosate Versus Naltrexone
NCT00656630 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Valproate on Ethanol Withdrawal
NCT03235531 ·Status: UNKNOWN ·Phase: PHASE4
-
Preliminary Human Trial of NPI-028
NCT00010907 ·Status: WITHDRAWN ·Phase: PHASE2
-
Soberlink Within In-Home Addiction Treatment Program
NCT03902171 ·Status: UNKNOWN
-
Deep Brain Stimulation for Refractory Alcoholism
NCT01798888 ·Status: WITHDRAWN ·Phase: PHASE1
-
Sex Differences in the Response to Abstinence From Alcohol.
NCT03827460 ·Status: RECRUITING ·Phase: PHASE1
-
Varenicline for Alcohol Dependence
NCT01146613 ·Status: COMPLETED ·Phase: PHASE2
-
Frontal-Striatal Reward Circuit Neuromodulation and Alcohol Self-Administration
NCT04971681 ·Status: TERMINATED ·Phase: NA
-
Intranasal Insulin for Treatment of Alcohol Use Disorder
NCT05988632 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Naltrexone for Relapse Prevention
NCT00000442 ·Status: COMPLETED ·Phase: PHASE4
-
Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal
NCT00936377 ·Status: COMPLETED ·Phase: NA